PRESS RELEASE published on 06/18/2024 at 10:00, 1 year 2 months ago Advancing Kidney Care With Solidified Evidence – SphingoTec Presents PenKid at AKI & CRRT Course in Vicenza SphingoTec introduces kidney function biomarker PenKid at AKI & CRRT Course. PenKid addresses AKI diagnostic gaps with real-time assessment and risk prediction capabilities SphingoTec PenKid Kidney Function Biomarker AKI & CRRT Course Biomarker Integration
BRIEF published on 03/26/2024 at 13:05, 1 year 5 months ago SphingoTec annonce des changements majeurs dans sa direction Biomarqueurs Innovations Diagnostiques Changements De Gestion SphingoTec Soin Critique
BRIEF published on 03/26/2024 at 13:05, 1 year 5 months ago SphingoTec Announces Major Management Changes Biomarkers Management Changes Diagnostic Innovations SphingoTec Critical Care
PRESS RELEASE published on 03/26/2024 at 13:00, 1 year 5 months ago SphingoTec Announces Management Changes SphingoTec announces changes in management team with new appointments. Deborah Bergmann appointed as CEO. Dr. Florian Uhle as CMO and Nicole Witzmann as CFO. Company aims to enhance critical care diagnostics Management Team Biomarkers SphingoTec Deborah Bergmann Critical Care Diagnostics
PRESS RELEASE published on 10/05/2023 at 10:00, 1 year 10 months ago New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients
PRESS RELEASE published on 09/06/2023 at 10:00, 1 year 11 months ago International Experts Highlight Demand for Diagnostic Innovations as PenKid's Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools
PRESS RELEASE published on 08/31/2023 at 12:30, 1 year 11 months ago Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
PRESS RELEASE published on 05/09/2023 at 10:00, 2 years 3 months ago SphingoTec's Innovative IVD Product sphingotest® penKid® Receives First IVDR Certificate
PRESS RELEASE published on 04/04/2023 at 10:00, 2 years 4 months ago ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury
PRESS RELEASE published on 02/23/2023 at 10:00, 2 years 6 months ago SphingoTec Appoints Dr. Florian Uhle as Medical Director
Published on 08/29/2025 at 16:45, 3 hours 34 minutes ago Gryphon Digital Mining Announces Stockholder Approval of Merger Transaction with American Bitcoin
Published on 08/29/2025 at 15:00, 5 hours 19 minutes ago NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 08/29/2025 at 14:00, 6 hours 19 minutes ago Temas Resources Corp. Lodges Prospectus on the ASX
Published on 08/29/2025 at 13:35, 6 hours 44 minutes ago Silver X Mining Corp. Sustains Pre-Tax Profitability Through 2Q25
Published on 08/29/2025 at 20:00, 18 minutes ago EQS-Adhoc: TTL Beteiligungs- und Grundbesitz-AG: Precautionary loss notification pursuant to Section 92 (1) of the German Stock Corporation Act (AktG)
Published on 08/29/2025 at 19:32, 47 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/29/2025 at 18:45, 1 hour 34 minutes ago VAT announces change in the Group Executive Committee
Published on 08/29/2025 at 18:15, 2 hours 3 minutes ago Funding Circle Holdings plc: TVR-Total Voting Rights
Published on 08/29/2025 at 18:09, 2 hours 9 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 08/29/2025 at 18:00, 2 hours 19 minutes ago Capital increase through exercise of subscription rights
Published on 08/29/2025 at 18:00, 2 hours 19 minutes ago Déclaration au titre de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers
Published on 08/29/2025 at 18:00, 2 hours 19 minutes ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 08/29/2025 at 17:40, 2 hours 39 minutes ago MISE A DISPOSITION RAPPORT FINANCIER ANNUEL 2024/2025
Published on 08/29/2025 at 17:04, 3 hours 15 minutes ago Information relative aux actifs d'Air Liquide en Russie
